Kirkland & Ellis advised Cole-Parmer, a portfolio company of GTCR, in its acquisition of ZeptoMetrix Corporation. ZeptoMetrix is a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases. The acquisition expands CP's quality controls and reference standards portfolio, and further establishes CP as a leading manufacturer of specialty chemistries and reagents for life sciences research and diagnostic testing. Read the GTCR press release The Kirkland team was led by transactional partners Chris Thomas, Michael Weed and Sanford Perl, and associates Edward Brennan and Kate Vandenberg; tax partners Gregory Gallagher and Polina Liberman; and debt finance partners Jocelyn Hirsch and Carolyn Aiken.